Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Post by YodaLayhehooon Sep 25, 2021 10:59pm
313 Views
Post# 33920165

Send in the clowns

Send in the clowns
Why is Canopy at a new 52 week low with little support. For a lot of reasons we've discussed.

1. Any reform that isn't full legalization hurts Canopy and helps the US MSOs gain market share in the US

The Market in Canada has turned out to be too small to sustain the market cap of multiple billion dollar companies.

They are burning cash badly while the companies in the US are EBITDA and cash flow positive.

The MSOs in the US have 10-20% quarter over quarter, not yearly growth rates. Canopy's sales declined last quarter and Growth in Canada is non existent.

Despite having two hands behind their backs the MSOs have surpassed Canopy in sales and profitability. They will double Canopy's sales next year some of them.

Last and worst of all Canopy is valued 2x and 3x higher than most of the larger MSOs except for Cura.

How can you expect a company with bigger losses and less revenue to trade 3x higher than larger profitable companies? And then still think that the stock will go up? You most definitely have a screen loose if you don't see a problem with this situation.

<< Previous
Bullboard Posts
Next >>